Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Cooper

Showing results (261-270 of 399) with videos related to

Pageof 40
Sort By:
Journal of the American Society of Nephrology : JASN|January 18, 2008
ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathyHans-Henrik Parving, Dick de Zeeuw, Mark E Cooper, et al.
Diabetes Care|December 12, 2007
Effect of LDL cholesterol and treatment with losartan on end-stage renal disease in the RENAAL studyAndrew M Tershakovec, William F Keane, Zhongxin Zhang, et al.
Endocrinology|November 18, 2006
Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy?Melinda T Coughlan, Vicki Thallas-Bonke, Josefa Pete, et al.
Antioxidants (Basel, Switzerland)|April 27, 2024
Endothelial NOX5 Obliterates the Reno-Protective Effect of Nox4 Deletion by Promoting Renal Fibrosis via Activation of EMT and ROS-Sensitive Pathways in DiabetesKarin A M Jandeleit-Dahm, Haritha R Kankanamalage, Aozhi Dai, et al.
Diabetes|September 8, 2011
Genetic examination of SETD7 and SUV39H1/H2 methyltransferases and the risk of diabetes complications in patients with type 1 diabetesAnna Syreeni, Assam El-Osta, Carol Forsblom, et al.
Circulation|November 11, 2009
Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol effluxAnna C Calkin, Brian G Drew, Akiko Ono, et al.
Kidney International|December 1, 2004
AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interactionKei Fukami, Seiji Ueda, Sho-ichi Yamagishi, et al.
Metabolism: Clinical and Experimental|March 5, 2010
The relationship between heat shock protein 72 expression in skeletal muscle and insulin sensitivity is dependent on adiposityDarren C Henstridge, Josephine M Forbes, Sally A Penfold, et al.
Critical Care Medicine|October 18, 2016
Protective Effect of Inflammasome Activation by Hydrogen Peroxide in a Mouse Model of Septic ShockOlivier Huet, Raelene J Pickering, Chris Tikellis, et al.
Diabetologia|January 9, 2018
Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trialSigrid C van Steen, Mark Woodward, John Chalmers, et al.
Pageof 40

Showing results (261-270 of 399) with videos related to

Sort By:
Pageof 40
Journal of the American Society of Nephrology : JASN|January 18, 2008
ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathyHans-Henrik Parving, Dick de Zeeuw, Mark E Cooper, et al.
Diabetes Care|December 12, 2007
Effect of LDL cholesterol and treatment with losartan on end-stage renal disease in the RENAAL studyAndrew M Tershakovec, William F Keane, Zhongxin Zhang, et al.
Endocrinology|November 18, 2006
Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy?Melinda T Coughlan, Vicki Thallas-Bonke, Josefa Pete, et al.
Antioxidants (Basel, Switzerland)|April 27, 2024
Endothelial NOX5 Obliterates the Reno-Protective Effect of Nox4 Deletion by Promoting Renal Fibrosis via Activation of EMT and ROS-Sensitive Pathways in DiabetesKarin A M Jandeleit-Dahm, Haritha R Kankanamalage, Aozhi Dai, et al.
Diabetes|September 8, 2011
Genetic examination of SETD7 and SUV39H1/H2 methyltransferases and the risk of diabetes complications in patients with type 1 diabetesAnna Syreeni, Assam El-Osta, Carol Forsblom, et al.
Circulation|November 11, 2009
Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol effluxAnna C Calkin, Brian G Drew, Akiko Ono, et al.
Kidney International|December 1, 2004
AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interactionKei Fukami, Seiji Ueda, Sho-ichi Yamagishi, et al.
Metabolism: Clinical and Experimental|March 5, 2010
The relationship between heat shock protein 72 expression in skeletal muscle and insulin sensitivity is dependent on adiposityDarren C Henstridge, Josephine M Forbes, Sally A Penfold, et al.
Critical Care Medicine|October 18, 2016
Protective Effect of Inflammasome Activation by Hydrogen Peroxide in a Mouse Model of Septic ShockOlivier Huet, Raelene J Pickering, Chris Tikellis, et al.
Diabetologia|January 9, 2018
Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trialSigrid C van Steen, Mark Woodward, John Chalmers, et al.
Pageof 40